share_log

山东新华制药股份(00719.HK):取得帕拉米韦注射液药品补充申请批准通知书

Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK): Obtained approval notice for supplemental application for peramivir injectable drugs

Gelonghui Finance ·  Apr 8 04:43

Gelonghui, April 8, 丨 Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK) issued an announcement. Recently, the company received the “Drug Supplement Application Approval Notice” for paramivir injection (15ml: 0.15g) approved by the State Drug Administration, and the transfer application of the product's marketing license holder was approved.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment